AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching

Competition is closing in on AbbVie’s blockbuster Botox franchise — despite the drugmaker’s best efforts to avoid it. In the meantime, the Chicago area drug giant can take some solace in a new indication that will add to the blockbuster drug’s war chest.